FDA Issues Warning Letter to Melanocorp, Inc. For Illegal Sale
FDA Issues Warning Letter to Melanocorp, Inc. For Illegal Sale of Melanotan II
FDA recommends that consumers who are currently using Melanotan II stop using this product and consult their health care provider if they have experienced any adverse events that they suspect are related to its use.